- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/38 - Heterocyclic compounds having sulfur as a ring hetero atom
Patent holdings for IPC class A61K 31/38
Total number of patents in this class: 534
10-year publication summary
|
26
|
18
|
26
|
21
|
17
|
16
|
14
|
33
|
17
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2315 |
17 |
| Shire Human Genetic Therapies, Inc. | 192 |
9 |
| Merck Sharp & Dohme Corp. | 2190 |
8 |
| The Regents of the University of California | 20268 |
6 |
| Flatley Discovery Lab, LLC | 19 |
6 |
| Mirum Pharmaceuticals, Inc. | 87 |
6 |
| Gilead Sciences, Inc. | 2085 |
5 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 840 |
5 |
| Sunshine Lake Pharma Co., Ltd. | 600 |
5 |
| Merck Sharp & Dohme LLC | 3732 |
5 |
| Glaxosmithkline LLC | 535 |
4 |
| Massachusetts Institute of Technology | 10130 |
4 |
| Lumena Pharmaceuticals, Inc. | 13 |
4 |
| Satiogen Pharmaceuticals, Inc. | 13 |
4 |
| University of Notre Dame du Lac | 581 |
4 |
| Sumitomo Dainippon Pharma Oncology, Inc. | 18 |
4 |
| Sitryx Therapeutics Limited | 43 |
4 |
| Vandria SA | 15 |
4 |
| Boehringer Ingelheim International GmbH | 4637 |
3 |
| Janssen Pharmaceutica N.V. | 3350 |
3 |
| Other owners | 424 |